Invacare Corporation (IVC)
Stock analysis · NYSE · Healthcare · Medical - Instruments & Supplies
Invacare Corporation (IVC) is a publicly traded company in the Healthcare sector. Latest price: $0.66. Market cap $24.91M. Trailing PE -0.24. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Proprietary Signals
About Invacare Corporation
Invacare Corporation, along with its affiliated entities, stands as a prominent international provider specializing in the design, production, distribution, and global export of medical devices. These products cater to diverse sectors, including home healthcare, retail environments, and long-term care facilities worldwide. Its extensive product portfolio encompasses mobility and seating solutions. These include power wheelchairs sold under the Invacare TDX brand, custom manual wheelchairs bearing the Invacare, Invacare Top End, and Küschall names, and various seating and positioning aids within the Invacare line. Furthermore, specialized custom molded seat modules are offered under the PinDot brand. Beyond mobility, Invacare supplies a range of daily living aids. This category features pressure-relieving overlays and mattress systems, such as the Invacare Softform and microAIR series; safe patient handling equipment like the Birdie, Evo, and ISA brands; and residential and institutional care beds along with their accessories, and certain manual wheelchairs, all primarily under the Invacare label. The company also provides personal care items. Additionally, the firm is a key suppli…
Valuation
| P/E (TTM) | -0.24× |
|---|---|
| P/S (TTM) | 0.03× |
| P/B | 0.30× |
| PEG | 0.00× |
| P/FCF (TTM) | -0.42× |
| EV / EBITDA | -9.01× |
| EV / Sales | 0.60× |
| Earnings Yield | -419.49% |
| Free Cash Flow Yield | -236.97% |
Fundamentals
| Enterprise Value | $442.54M |
|---|---|
| Revenue (TTM) | $741.73M |
| Net Income (TTM) | -$104.50M |
| Free Cash Flow (TTM) | -$29.62M |
| Net Debt | $417.63M |
| Working Capital | $79.18M |
| Gross Margin | 23.65% |
| Operating Margin | -9.37% |
| Net Margin | -13.63% |
| Return on Equity | -46.11% |
| Return on Invested Capital | -12.54% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap